Cargando…

Prediction of survival of diffuse large B‐cell lymphoma patients via the expression of three inflammatory genes

Currently, several gene‐expression signatures that were used to predict survival of diffuse large B‐cell lymphoma (DLBCL) patients, showed a restriction on the practical work for lack of convenient operation. In this study, we screened inflammatory genes whose expression correlated with survival of...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhao, Shuangtao, Bai, Nan, Cui, Jianlin, Xiang, Rong, Li, Na
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2016
Materias:	Cancer Biology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4971923/ https://www.ncbi.nlm.nih.gov/pubmed/27394196 http://dx.doi.org/10.1002/cam4.714

Ejemplares similares

Machine learning‐based classification of diffuse large B‐cell lymphoma patients by eight gene expression profiles
por: Zhao, Shuangtao, et al.
Publicado: (2016)

OSdlbcl: An online consensus survival analysis web server based on gene expression profiles of diffuse large B‐cell lymphoma
por: Dong, Huan, et al.
Publicado: (2020)

MicroRNA-142 is mutated in about 20% of diffuse large B-cell lymphoma
por: Kwanhian, Wiyada, et al.
Publicado: (2012)

miR‐155‐regulated mTOR and Toll‐like receptor 5 in gastric diffuse large B‐cell lymphoma
por: Huang, Wei‐Ting, et al.
Publicado: (2021)

Induction of autophagy and autophagy‐dependent apoptosis in diffuse large B‐cell lymphoma by a new antimalarial artemisinin derivative, SM1044
por: Cheng, Chunyan, et al.
Publicado: (2017)

The effectiveness of rituximab and HIV on the survival of Ontario patients with diffuse large B‐cell lymphoma
por: Habbous, Steven, et al.
Publicado: (2020)

Associations between race and survival in pediatric patients with diffuse large B‐cell lymphoma
por: Khullar, Karishma, et al.
Publicado: (2021)

JMJD3 promotes survival of diffuse large B-cell lymphoma subtypes via distinct mechanisms
por: Zhang, Yan, et al.
Publicado: (2016)

Differential expression of miRNAs as biomarkers for predicting the outcomes of diffuse large B-cell lymphoma patients
por: Hu, Maogui, et al.
Publicado: (2021)

Surgery shows survival benefit in patients with primary intestinal diffuse large B‐cell lymphoma: A population‐based study
por: Wang, Moran, et al.
Publicado: (2021)

Diffuse Large B-Cell Lymphoma in the Era of Precision Oncology: How Imaging Is Helpful
por: Shah, Hina J., et al.
Publicado: (2017)

Interim PET/CT based on visual and semiquantitative analysis predicts survival in patients with diffuse large B‐cell lymphoma
por: Li, Xiaoqian, et al.
Publicado: (2019)

Recent survival trends in diffuse large B‐cell lymphoma––Have we made any progress beyond rituximab?
por: Epperla, Narendranath, et al.
Publicado: (2020)

β-Elemene suppresses tumor growth of diffuse large B-cell lymphoma through regulating lncRNA HULC-mediated apoptotic pathway
por: Hu, Tonglin, et al.
Publicado: (2020)

The impact of structural factors on diagnostic delay in diffuse large B‐cell lymphoma
por: Zurko, Joanna C., et al.
Publicado: (2019)

PD‐1 expression on the surface of peripheral blood CD4(+) T cell and its association with the prognosis of patients with diffuse large B‐cell lymphoma
por: Zhang, Wei, et al.
Publicado: (2016)

Microsatellite instability and its associations with the clinicopathologic characteristics of diffuse large B‐cell lymphoma
por: Tian, Tian, et al.
Publicado: (2020)

Development of a novel cell line‐derived xenograft model of primary herpesvirus 8‐unrelated effusion large B‐cell lymphoma and antitumor activity of birabresib in vitro and in vivo
por: Nishimori, Tomohiro, et al.
Publicado: (2021)

The average relative dose intensity of R‐CHOP is an independent factor determining favorable overall survival in diffuse large B‐cell lymphoma patients
por: Długosz‐Danecka, Monika, et al.
Publicado: (2019)

The Dark Side of Pyroptosis of Diffuse Large B-Cell Lymphoma in B-Cell Non-Hodgkin Lymphoma: Mediating the Specific Inflammatory Microenvironment
por: Wang, Wei, et al.
Publicado: (2021)

The beneficial effect of Escalated‐R‐CHOP‐21 for the treatment of diffuse large B‐cell lymphoma in elderly male patients: A propensity‐matched cohort study
por: He, Hai‐Xia, et al.
Publicado: (2021)

Activated hippo signal pathway inhibits cell proliferation and promotes apoptosis in NK/T cell lymphoma cells
por: Chang, Yu, et al.
Publicado: (2019)

PD‐L1 (SP142) expression in neoplastic cells predicts a poor prognosis for patients with intravascular large B‐cell lymphoma treated with rituximab‐based multi‐agent chemotherapy
por: Suzuki, Yuka, et al.
Publicado: (2020)

Complications and outcomes in diffuse large B‐cell lymphoma with gastric lesions treated with R‐CHOP
por: Kadota, Tomohiro, et al.
Publicado: (2019)

Comprehensive machine-learning survival framework develops a consensus model in large-scale multicenter cohorts for pancreatic cancer
por: Wang, Libo, et al.
Publicado: (2022)

Oxaliplatin regulates myeloid‐derived suppressor cell‐mediated immunosuppression via downregulation of nuclear factor‐κB signaling
por: Kim, Na‐Rae, et al.
Publicado: (2018)

Bone marrow biopsy superiority over PET/CT in predicting progression‐free survival in a homogeneously‐treated cohort of diffuse large B‐cell lymphoma
por: Chen‐Liang, Tzu‐Hua, et al.
Publicado: (2017)

A better prediction of progression‐free survival in diffuse large B‐cell lymphoma by a prognostic model consisting of baseline TLG and %ΔSUV(max)
por: Zhang, Yi‐Yang, et al.
Publicado: (2019)

Coexpression of CD5 and CD43 predicts worse prognosis in diffuse large B‐cell lymphoma
por: Ma, Xiao‐bo, et al.
Publicado: (2018)

Identification of an individualized RNA binding protein‐based prognostic signature for diffuse large B‐cell lymphoma
por: Xie, Yongzhi, et al.
Publicado: (2021)

A prognostic model, including the EBV status of tumor cells, for primary gastric diffuse large B‐cell lymphoma in the rituximab era
por: Ishikawa, Eri, et al.
Publicado: (2018)

Inflammatory Cells in Diffuse Large B Cell Lymphoma
por: Tamma, Roberto, et al.
Publicado: (2020)

Expression of Tim‐1 in primary CNS lymphoma
por: Kishimoto, Wataru, et al.
Publicado: (2016)

EBV‐positive B‐cell lymphomas and lymphoproliferative disorders: Review from the perspective of immune escape and immunodeficiency
por: Satou, Akira, et al.
Publicado: (2021)

Membrane interactions of the globular domain and the hypervariable region of KRAS4b define its unique diffusion behavior
por: Goswami, Debanjan, et al.
Publicado: (2020)

Malic enzyme 2 promotes the progression of hepatocellular carcinoma via increasing triglyceride production
por: Zhang, Shuai, et al.
Publicado: (2021)

Comparison of PD‐L1 detection assays and corresponding significance in evaluation of diffuse large B‐cell lymphoma
por: Huang, Sixia, et al.
Publicado: (2019)

Next‐generation sequencing of miRNAs in clinical samples of Epstein–Barr virus‐associated B‐cell lymphomas
por: Sakamoto, Kouta, et al.
Publicado: (2017)

Expression of telomerase reverse transcriptase in peripheral T‐cell lymphoma
por: Arakawa, Fumiko, et al.
Publicado: (2021)

Isolation and characterization of spontaneously immortalized B‐lymphocyte lines from HIV‐infected patients with and without non‐Hodgkin's Lymphoma
por: Zhuang, Ke, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_jpqpj26ucaruciu9qojq67e98u